A new UK study has highlighted the critical role of GP data in understanding atrial fibrillation (AF), the most common form ...

Baxter International has appointed Brent Shafer, who has been serving as the company’s Lead Independent Director, as Chair ...

NHS England has launched its first-ever breast cancer awareness campaign aimed at highlighting the benefits of screening for ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and ...

The University of Bath has received a £3.5 million Wellcome grant to study cognitive decline and premature brain ageing in ...

Baxter International has appointed Heather Knight, who has been leading the company’s Medical Products and Therapies unit, as Executive Vice President and Chief Operating Officer (COO).

Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY (garadacimab), the ...

After two years of treatment with bimekizumab, 53.1% of patients experienced mild disease compared to none at baseline.

The methodology, created in the bespoke gen AI-driven biotechnology lab of Cambridge Consultants, part of the Capgemini Group ...

Qureight Ltd and Avalyn Pharma Inc have announced a strategic partnership in progressive pulmonary fibrosis (PPF). The ...

Regeneron UK Limited has announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo (cemiplimab) for use on ...